Otsuka Pharmaceutical Co., Ltd.

Pharmaceuticals, Biotechnology and Life Sciences

Targets set2°C

SBTI ID

40007366

Informations générales

Localisation

Japan

Asia

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

26/09/2019

Objectifs à court terme (Near-Term)

Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

2°C

Année cible

2030

Progression vers l'objectif73%

2015 (année de référence)2030

Description complète des objectifs

Pharmaceutical company Otsuka Pharmaceutical Co. , Ltd. commits to reduce absolute scope 1 and 2 GHG emissions 30% by 2030 from a 2017 base year. Otsuka Pharmaceutical also commits to reduce absolute scope 3 GHG emissions 20% by 2030 from a 2017 base year.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 2°C

Source : Science Based Targets initiative | Données publiques